Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oramed Pharmaceuticals Inc

+ Add to Watchlist

ORMP:US

7.1800 USD 0.00000.00%

As of 16:00:00 ET on 04/28/2015.

Snapshot for Oramed Pharmaceuticals Inc (ORMP)

Open: 7.3000 Day's Range: 7.0710 - 7.8900 Volume: 132,753
Previous Close: 7.1800 52wk Range: 3.7125 - 11.7999 1-Yr Rtn: -32.49%

Stock Chart for ORMP

No chart data available.
  • ORMP:US 7.2100
  • 1D
  • 1M
  • 1Y
7.1800
Interactive ORMP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORMP

Current P/E Ratio (ttm) -
Estimated P/E(08/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7000
Est. EPS (USD) (08/2015) -0.5600
Est. PEG Ratio -
Market Cap (M USD) 80.64
Shares Outstanding (M) 10.82
30 Day Average Volume 605,181
Price/Book (mrq) 3.5003
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORMP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ORMP

Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.

Nadav KidronPresident/CEOYifat ZommerCFO/Treasurer/Secretary
Miriam KidronChief Medical & Tech OfficerJoshua Hexter "Josh"VP:Business Dev/COO
More Company Profile & Key Executives for ORMP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil